Emmessar Biotech & Nutrition Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

5.00

5.00

5.00

5.00

5.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1.67

1.17

0.70

-0.73

-1.49

Loan funds

Secured loans

0.08

-

-

-

0.07

Unsecured loans

-

-

-

-

-

Total

6.75

6.17

5.70

4.26

3.58

Uses of funds

Fixed assets

Gross block

2.65

2.63

2.34

2.35

2.39

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.65

0.56

0.48

0.43

0.40

Net block

2.00

2.07

1.86

1.91

1.99

Capital work-in-progress

-

-

-

-

-

Investments

0.01

0.01

0.01

0.01

0.01

Net current assets

Current assets, loans & advances

5.93

5.13

5.94

4.21

3.17

Less : current liabilities & provisions

1.20

1.04

2.11

1.87

1.58

Total net current assets

4.73

4.09

3.83

2.34

1.59

Miscellaneous expenses not written

-

-

-

-

-

Total

6.75

6.17

5.70

4.26

3.58

Notes:

Book value of unquoted investments

0.01

0.01

0.01

-

0.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

49.96

49.96

49.96

49.96

49.96